Pneumotyl Adverse Reactions

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Full Prescribing Info

Adverse Reactions

The evaluation of adverse reactions is based on the following information on frequencies: Very common: (≥1/10); Common: (≥1/100 up to <1/10); Uncommon: ( ≥1/1,000 up to <1/100); Rare: (≥1/10,000 up to <1/1,000); Very rare: (<1/10,000); Not known: (cannot be estimated from the available data).
Immune system disorders:Uncommon: Hypersensitivity reactions; Very rare: Anaphylactic shock, anaphylactic/anaphylactoid reactions.
Nervous system disorders: Uncommon: Headache.
Ear and labyrinth disorders: Uncommon: Tinnitus.
Cardiac disorders: Uncommon: Tachycardia.
Vascular disorders: Uncommon: Hypotension; Very rare: Hemorrhage.
Respiratory, thoracic and mediastinal disorders: Rare: Dyspnoea, bronchospasm.
Gastrointestinal disorders: Uncommon: Nausea, vomiting, diarrhoea, abdominal pain; Rare: Dyspepsia.
Skin and subcutaneous tissue disorders: Uncommon: Urticaria, rash, angioedema, itching, exanthema.
General disorders and administration site conditions: Uncommon: Fever; Not known: Facial edema.
A decreased blood platelet aggregation in the presence of acetylcysteine has been confirmed by different studies. The clinical relevance has not yet been clarified to date.

View ADR Monitoring Form

acetylcysteine

Manufacturer:

Hermes

Distributor:

Natrapharm